Effect of talquetamab on responses in patients with relapsed and refractory multiple myeloma with prior exposure to T-cell directed therapies.

Authors

null

Allison Graeter

University of South Florida, Tampa, FL

Allison Graeter , Omar Alexis Castaneda Puglianini , Doris K. Hansen , Mariola A. Vazquez-Martinez , Brandon Jamaal Blue , Sushmita Khadka , Hien Liu , Jose L. Ochoa-Bayona , Ciara L. Freeman , Frederick L Locke , Taiga Nishihori , Kenneth H. Shain , Rachid C. Baz , Melissa Alsina , Ariel Felipe Grajales-Cruz

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Hematologic Malignancies—Plasma Cell Dyscrasia

Track

Hematologic Malignancies

Sub Track

Cell Therapy, Bispecific Antibodies, and Autologous Stem Cell Transplantation for Plasma Cell Disorders

Citation

J Clin Oncol 42, 2024 (suppl 16; abstr 7524)

DOI

10.1200/JCO.2024.42.16_suppl.7524

Abstract #

7524

Poster Bd #

161

Abstract Disclosures